Sunteți pe pagina 1din 8

LabNotes

A Newsletter from
BD Diagnostics
Volume 20, No.1, 2009

Preanalytical Systems

Capillary Blood Collection:


Best Practices
Compiled by Nancy Niwinski, MT(ASCP)

Skin puncture or capillary blood collection performed, especially if the test(s) requested
involves puncturing the dermis layer of the requires only a small volume of blood
skin to access the capillary beds which run Patients with burns or scarring in
through the subcutaneous layer of the skin. venous blood collection sites
Blood obtained via skin puncture is a mixture
of undetermined proportions of blood from Extremely obese patients
arterioles, venules, capillaries, plus interstitial Patients requiring frequent blood tests
and intracellular fluids. The proportion of
arterial blood is greater than that of venous Patients receiving IV therapy in both
blood, due to the increased pressure in the arms or hands
arterioles leading into the capillaries versus Patients at risk for serious complications

Bonus! the pressure in the venules exiting the


capillaries. Warming of the puncture site
associated with venipuncture, venous
thrombosis, or deep venous puncture
further arterializes the blood and increases (e.g. deep vein puncture in infants,
blood flow. thrombophlebitis)
Patients requiring only one blood test for
Removable Capillary blood collection is the preferred
method of blood specimen collection for which a capillary specimen is appropriate
Wall Chart newborns and infants. Clinical Laboratory Patients whose veins are reserved for
Inside! Standards Institute (CLSI) recommends
capillary blood collection via heelstick
intravenous therapy or chemotherapy
Point-of-care testing where only a few
for infants less than one year of age.1 drops of blood are needed
For children older than one year, capillary
blood collection via fingerstick should be
considered, where appropriate. Capillary blood collection is inappropriate for:
Severely dehydrated patients
Capillary blood collection may also
be used for adults under certain Patients with poor circulation
circumstances including: Coagulation studies requiring
Patients with fragile, superficial plasma specimens
View
or difficult to access veins Tests that require large volumes of blood
LabNotes
Patients where multiple unsuccessful (i.e. Erythrocyte Sedimentation Rate (ESR)
Online or Sign Up
venipunctures have already been and blood cultures)
for e-LabNotes
at
continued on page 2
bd.com/labnotes

This publication is a service to the customers and friends of BD, and is designed only to provide

general information. It is not intended to be comprehensive or provide any legal or medical advice.
Capillary Blood Collection: Best Practices

LabNotes
continued from page 1

It is important to understand that there are


differences between some analytes in capillary blood
as compared to venous or arterial blood specimens.
Letter from the editor Glucose, potassium, total protein, and calcium have
The feature article in this LabNotes focuses on capillary been reported to show statistically and/or clinically
blood collection. This form of specimen collection important differences. With the exception of
requires skill and practice by the blood collector to glucose, the concentration of these analytes is lower
ensure that a good quality sample is obtained and ready in capillary blood.
for analysis. The article will provide you with an overview
of situations where skin puncture is the collection method The following tests are commonly performed
of choice, and it will give several tips on proper specimen using capillary blood:
collection technique.
Point-of-Care testing (POCT, i.e. blood
Also in this issue, BD Diagnostics Preanalytical Systems glucose monitoring)
is proud to announce its newest member of the
BD Vacutainer evacuated blood collection tube family, Complete Blood Count (CBC), hemoglobin
Dr. Ana Stankovic
the BD Vacutiner Rapid Serum Tube (RST). The BD & hematocrit (H&H)
RST tube will provide a clotted specimen in five minutes, Peripheral Blood Smear (manual slide for
which will help you to improve your turn-around times,
white blood cell (WBC) differential)
particularly in a STAT setting. Please take a look at the
full article for more details about the RST tube, and feel Neonatal Blood Gases
free to contact your local BD Sales Consultant for
Neonatal Bilirubin
additional information.
Neonatal Screening (filter paper or blood
The BD Global Technical Services Department is one
of BDs value-added services that you, our customers,
spot testing)
can take advantage of when you have a technical Electrolytes
question about BD products. Be sure to see the details
about our technical experts on the last page
The recommended Order of Draw for capillary
of LabNotes.
blood collection is different from blood specimens
We hope you enjoy this issue and find the information drawn by venipuncture. CLSI recommends the
in the articles beneficial in your everyday practice. following order of draw for skin puncture:1
Regards, Blood gases
The Vacutainer Brand
and Trademark EDTA tubes
Trademarks were developed to Other additive tubes
protect the consumer from confusion
as to the source of products and Dr. Ana K. Stankovic, Editor Serum tubes
services available in the marketplace.
Trademarks identify and distinguish MD, PhD, MSPH
the source of goods or services of Worldwide Vice President, Medical and
After warming (arterializing) the site, it is
one party from those of another. Scientific Affairs and Clinical Operation recommended to collect capillary blood gases first,
Trademarks, otherwise known as BD Diagnostics Preanalytical Systems as the blood becomes increasingly more venous
brands, are intellectual property and Email: Ana_Stankovic@bd.com if the collection is delayed. Likewise, if collection of
are part of the assets or good will blood for a CBC (K2EDTA tubes) is delayed, there is
of a company.
Editorial Staff an increased likelihood of erroneous cell counts due
On LabNotes, and many other pieces to platelet clumping.
Susan Stansfield LabNotes Production Manager
of information you receive from
BD and on our Web site, you see the Leslie S. Magee, MBA, MT(ASCP)
Julie Ravo
Vacutainer Brand represented with
Sara Eames
Device Selection See Adjacent chart
the registered trademark symbol .
Vacutainer is a registered trademark Charlie Kim There are two types of lancing
of Becton, Dickinson and Company. devices that are used for collection of capillary blood:
This brand name is officially registered puncture devices and incision devices. Puncture
with the US Trademark office and
many other local trademark authorities
devices (e.g. BD Microtainer Contact-Activated
worldwide, and is legally owned by BD. Lancets) puncture the skin by inserting either a needle
or blade vertically into the tissue. Puncture devices
are preferable for sites that are repeatedly punctured
(i.e. blood glucose monitoring). Incision devices
(e.g. BD Microtainer Quikheel Lancets) slice
through the capillary beds. Incision devices are less
painful than puncture devices and require fewer
Address all correspondence to: repeat incisions and shorter collection times, and
Leslie Magee, Associate Editor, LabNotes are therefore, recommended, especially for infant
BD Diagnostics Preanalytical Systems, heelsticks.2 Both types of devices come in a variety
1 Becton Drive MC325
Franklin Lakes, NJ USA 07417-1885
of styles, sizes and depths.
2 www.bd.com/vacutainer
www.bd.com/vacutainer 3

Device Device Name Device Type Width x Depth (mm) Intended Use4
Fingerstick Low Flow
BD Microtainer (single drop)
Puncture
Contact-Activated 30 G x 1.5 mm
(needle) Demonstrates significantly less pain for
Lancet (Purple)
your patients than comparable products*

BD Microtainer
Puncture
Contact-Activated 21 G x 1.8 mm Fingerstick Medium Flow
(needle)
Lancet (Pink)

BD Microtainer
Puncture Fingerstick High Flow
Contact-Activated 1.5 mm x 2.0 mm
(blade) (500 L from single puncture)
Lancet (Blue)

Heelstick Low Flow (premature infants)


BD Microtainer
Incision Low birth-weight babies or full-term
Quikheel Lancet 1.75 mm x 0.85 mm
(blade) infants where lower blood volume
(Pink)
is required

BD Microtainer Heelstick High Flow (infants)


Incision
Quikheel Lancet 2.5 mm x 1.0 mm Full-term infants where higher
(blade)
(Teal) blood volume is required
* BD Clinical Documentation VS7499

According to CLSI, a skin puncture device should be a sterile, often calloused and potentially more sensitive to pain due to
disposable, single-use device with a permanently retractable additional nerve endings. The thumb also may be calloused
blade or needle to reduce the possibility of accidental and has a pulse, indicating arterial presence, and, therefore,
needlestick injuries and reuse.1 The use of manual lancets should be avoided. The distance between the skin surface
or blades without a retractable feature is a violation of and the bone in the fifth finger also makes it unsuitable for
OSHA regulations.3 puncture. The side and tip of the finger should be avoided,
as the tissue is about half as thick as the central portion of
the fingertip.
General Site Selection
The patients age, accessibility of the puncture site, and the
blood volume required should all be taken into consideration Heelstick Site Selection
when selecting the skin puncture device type and puncture The recommended site for heel punctures
site. Select a site that is warm, pink and free of any calluses, is the lateral (outside) or medial (inside)
burns, cuts, scars, bruises, or rashes. The site should not be plantar surface of the heel. In small or
cyanotic (bluish from lack of oxygen), edematous (swollen), premature infants, the heel bone (calcaneus)
or infected. Avoid skin areas that have evidence of previous may be no more than 2.0 mm beneath
punctures or are otherwise compromised. the skin surface and no more than half
this distance at the posterior curvature
of the heel. Puncturing deeper than 2.0 mm on the plantar
Fingerstick Site Selection
surface of the heel of small infants may, therefore, risk bone
The recommended site for capillary collection on adults and damage. When using incision devices, puncturing the heel at
children over one year of age is the palmar surface of the a 90 angle to the length of the foot is recommended.5 Such
distal (end) segment of the third (middle) or fourth (ring) incisions create a gap puncture (one which opens when
finger, ideally of the non-dominant hand. Fingers on the non- pressure is applied) and further enhance blood flow.
dominant hand are generally less calloused. The puncture
should be made slightly off center from the central, For infants, punctures must not be performed on:
fleshy portion of the fingertip and if
using a blade-type puncture device, The posterior curvature of the heel.
perpendicular to the fingerprint The central area of an infants foot (area of the arch).
whorls. Puncturing along or Punctures to this area may result in injury to nerves,
parallel to the whorls may cause tendons, and cartilage.
the blood to follow the pattern
The fingers of a newborn or infant less than one year old.
of the fingerprint, redirecting
the flow and making it more Earlobes.
difficult to collect.
The index finger is continued on next page

LabNotes: a newsletter from BD Diagnostics Preanalytical Systems, Volume 20, No.1, 2009
Capillary Blood Collection: Best Practices

continued from previous page

Best Practice for Capillary Blood Collection


The following steps should be performed in accordance with the facilities recommended procedures.

A Review the test requisition(s). K Puncture the skin with the disposable lancing/incision
device.
B Gather the appropriate supplies (lancing device, gloves,
gauze, alcohol, bandages, etc.). L Wipe away the first drop of blood with a dry gauze
pad (refer to each point-of-care device manufacturers
C Positively identify the patient. instructions).

4 Verify diet restrictions (fasting required, etc.) and any latex M Collect the specimen in the appropriate container, and mix
sensitivity (if products containing latex are being used). according to the manufacturers instructions.

5 Wash hands and put on gloves. N Seal the specimen container.


 OTE: All patient and laboratory specimens are treated as potentially
N
infectious and handled according to standard precautions. Standard Apply direct pressure to the wound site with a clean gauze
precaution guidelines are available from the U.S. Centers for Disease pad and slightly elevate the extremity.
Control and Prevention (www.cdc.gov).
Label the specimen container in direct view of the patient
6 The patient should be sitting or lying down. or guardian to verify identification, and record time of
collection. Label each container individually.
7 Select appropriate puncture site.
Properly dispose of the lancet/incision device in a
8 Warm the puncture site. puncture-resistant disposal container.

9 Clean the puncture site with 70% isopropyl alcohol and Properly dispose of any other contaminated materials
allow to air dry. The site must be allowed to air dry in (gloves, gauze, etc.) in a container approved for their
order to provide effective disinfection. disposal.

J Notify older children and adults of the imminent puncture. S After removing gloves, wash hands before proceeding to
the next patient.

Special Specimen Collection Requirements

A Bilirubin samples must be protected from light, both B For newborn screening (filter paper collection), gently
during and after collection, as light breaks down bilirubin. touch the filter paper against the blood drop in a single
If collecting a capillary specimen from an infant in an step to allow a sufficient quantity of blood to soak
incubator, turn off the ultraviolet (UV) light source above completely through the paper and fill the preprinted circle.
the infant during specimen collection.6 Collect capillary The paper must not be pressed against the puncture site
blood specimen quickly to minimize exposure of the blood on the heel. If the circle does not fill entirely, wipe the
specimen to light. Use amber collection containers or foil heel and touch a different circle to the blood drop until
to protect specimens from light. Ensure that the UV light the circle is completely filled. Blood must soak through
is turned back on before leaving the nursery. the paper within the circle to the other side, and must be
applied to one side of the paper only.

4 www.bd.com/vacutainer
LabNotes: a newsletter from BD Diagnostics Preanalytical Systems, Volume 20, No.1, 2009 www.bd.com/vacutainer 5

Top 10 Keys to Obtaining a High Quality Capillary Blood Specimen

A Positively Identify the Patient Positive identification effects of platelet clumping and microclot formation
of the patient is the most important step in specimen (hematology testing). Specimens also should be collected
collection. Patient misidentification can lead to incorrect quickly to avoid exposure to atmospheric air and light
diagnosis, therapy and treatment. The consequences can (blood gases and bilirubin testing).
be serious, even fatal to the patient.
8 Fill to the Correct Fill Volume Fill containers to the
B Puncture Site and Lancing/Incision Device Selection recommended fill volume (if indicated). Underfilled
Determine the appropriate puncture site and lancing/ containers will have higher concentrations of additives.
incision device for the patient and the tests requested. For K2EDTA, higher concentrations may cause erroneous
Using the wrong size lancet/incision device may result in results for MCV and red cell indices and cause RBC and
excessive squeezing, prolonged or incomplete collection, WBC morphological artifacts. Consequently, overfilled
poor specimen quality (hemolysis, clotting) and possible containers will have lower concentrations of EDTA and
redraws, as well as injury to the patient (mainly children). may result in clotting.7

C Warming the Puncture Site Only a limited amount of 9 Mix Specimen Microcollection tubes must be inverted
blood will easily flow from a capillary puncture. Warming the appropriate number of times to ensure that the
the puncture site will increase blood flow up to seven blood and anticoagulant are sufficiently mixed. Mixing
times and is critical for the collection of blood gases and is essential to prevent the formation of microclots and
pH specimens. CLSI guidelines recommend warming the platelet clumps, which can cause inaccurate or erroneous
skin puncture site for three - five minutes with a moist test results. Small clots can also occlude sample aspiration
towel or commercially available warming device at a probes or tubing in laboratory instruments, resulting
temperature no greater than 42C.1 in instrument downtime and/or additional unscheduled
maintenance. While modern analyzers have sophisticated
4 Cleaning the Puncture Site Allow the alcohol to air detection systems to recognize platelet clumps, it is still
dry. Performing skin puncture through residual alcohol possible for platelet clumps to cause erroneous test results
may cause hemolysis and can adversely affect test results. (e.g. platelet count, platelet volume, red cell volume,
It also may cause additional discomfort for the patient. white cell count). Adequate mixing, both during and after
Do not use povidone-iodine to cleanse the puncture the completion of capillary blood collection, will help
site. Povidone-iodine interferes with bilirubin, uric acid, minimize these occurrences.
phosphorus and potassium.
J Properly Label Specimen Each tube should be
5 Wipe Away the First Drop of Blood Immediately individually labeled at the bedside prior to leaving the
following skin puncture, platelets aggregate at the area. Mislabeling of the specimen can lead to incorrect
puncture site to form a platelet plug, initiating the clotting diagnosis, therapy and treatment. The consequences can
process. Without wiping away the platelet plug, bleeding be serious, even fatal, for the patient.
may stop prior to completion of the blood collection, In summary, there truly is an art to capillary blood
resulting in insufficient blood volume and redraws. In collection. These 10 steps provide guidelines to assist your
addition, the first drop of blood contains tissue fluid, facility in selecting the appropriate lancing/incision device
which can cause specimen dilution, hemolysis and clotting. and puncture site for a successful capillary blood collection
 OTE: For point-of-care testing (i.e. blood glucose monitoring), use of
N the first time. A high-quality specimen minimizes errors and
the first drop of blood may be appropriate. Refer to the manufacturers possible re-draws, while enhancing customer satisfaction and
instructions for use. patient care.

6 Avoid Milking, Scooping or Scraping of the Puncture


Site It is recommended to touch the collector end of the References
container to the drop of blood. After collecting 2 or 3 1. C
 LSI H4-A6. Procedures and Devices for the Collection of Diagnostic Blood Specimen
drops, the blood will freely flow down the container wall by Skin Puncture; Approved StandardSixth Edition, Vol. 24, No. 21, 2008.
to the bottom of the tube. Excessive squeezing (milking), 2. S hah V, Taddio A, Kulasekaran K, et al. Evaluation of a new lancet device
scooping and scraping may cause hemolysis and/or tissue (BD QuikHeel) on pain response and success of procedure in term neonates.
Arch Pediatr Adolesc Med 2003;157:1075-1078.
fluid contamination of the specimen. Using a scooping
3. B
 loodborne Pathogens and Needlestick Prevention. Occupational Safety & Health
or scraping motion along the surface of the skin can also Administration. Available at: www.osha.gov/SLTC/bloodbornepathogens/index.html
result in platelet activation, promoting platelet clumping 4. P roduct literature. BD Microtainer Contact-Activated Lancet. Becton, Dickinson
and clotting. and Company, 2006.
5. Product literature. BD Quikheel Safety Lancet.
7 Collect Specimen Quickly Puncturing the skin releases 6. M
 c Call RE, Tankersley CM. Phlebotomy Essentials. Lippincott Williams & Wilkins,
Philadelphia, PA: 2007:384.
thromboplastin, which activates the coagulation process.
7. Ernst D. Minimum blood volume for CBC tubes. Medical Laboratory Observer, 2005.
Specimens must be collected quickly to minimize the
BD RST at A Glance:
5  -minute clotting time
Potential for improvements in laboratory
workflow efficiency and turnaround time
Quality serum specimen
Reduction in hemolysis
Accurate results

Quality Serum Specimens with the Speed of Plasma


Introducing the BD Vacutainer Rapid Serum Tube
When Every Minute Counts
The need for improved workflow remains at the forefront workflow. In addition, in a recent study conducted by BD in
of efficient laboratory management. This has placed the Czech Republic, the combination of the BD RST using
additional emphasis on laboratory resources, both in the a 3-minute centrifuge time on the StatSpin Express 3
private and hospital sectors, to deliver quality services and centrifuge led to significantly faster preanalytical turnaround
enhance productivity. In addition, the demands for improved time by an average of 38.5 minutes.2 The increased test result
throughput have reiterated the focus on more rapid receipt turnaround time may potentially lead to more rapid diagnosis
of test results as well as reduction in preanalytical errors and treatment planning, which are vital for patients in many
(e.g. hemolysisa major reason for specimen rejection), hospital units (e.g. emergency, cardiac, intensive care). Faster
which require sample re-draws and re-work, contributing to patient diagnosis and treatment in the Emergency Department
delays in report time. As such, more and more laboratories (ED) accelerate discharge or admission, which decrease the
are including turnaround time as a key performance indicator overall length of stay in the ED. As a result, the ED can
of their services. However, many have difficulty in meeting increase patient throughput and reduce patient diversions,
these goals.1 all key services for hospitals today.

To address the needs for improved workflow efficiency and


turnaround time, BD Diagnostics Preanalytical Systems has Clinically Proven Performance
introduced a new fast-clotting serum blood collection tube in In order to demonstrate the clinical performance of the
the USthe BD Vacutainer Rapid Serum Tube (BD RST). BD RST, seven clinical studies were conducted to evaluate
The BD RST is a 4mL-draw, 13x100mm plastic sterile blood the BD RST for a wide range of clinical chemistry assays
collection tube with a gel separator and a thrombin additive. routine and special chemistry analytes (e.g. cardiac markers,
The thrombin additive promotes rapid clotting of the blood, female hormones, thyroid hormones). In addition, selected
allowing the BD RST to be centrifuged five minutes after analytes in immunology were also evaluated (e.g. C3, C4,
collection to provide a quality serum specimen that can IgG, IgM). Following blood collection by routine venipuncture,
be sampled directly from the primary tube. the studies were performed to assess the tubes efficacy and
spanned a wide range of patient populations (apparently
The five-minute clotting time of the BD RST represents healthy adult subjects, cardiac patients, pregnant subjects,
a significant reduction in clotting time as compared with patients with a range of clinical diagnoses and conditions).
traditional serum gel tubes, which typically require a
minimum clotting time of 30 minutes. This may result in
a time savings of up to 25 minutes, improving laboratory

6 www.bd.com/vacutainer
LabNotes: a newsletter from BD Diagnostics Preanalytical Systems, Volume 20, No.1, 2009 www.bd.com/vacutainer 7

Clinical performance was evaluated on a range of instrument


platforms* including: LabNotes Tip

Abbott AxSYM BD Microtainer Tubes with


BD Microgard Closure
Bayer ADVIA Centaur
Beckman Coulter Access 2 Order of Draw
DPC Immulite1000
Olympus AU5200/AU5400 Catalog #/ Mix by
Additive
Ortho Clinical Diagnostics VITROS ECi Closure Color Inverting
Ortho Clinical Diagnostics VITROS 5,1 FS
Roche COBAS Integra 800 K2EDTA 10x
365974 Lavender
Roche Modular

The performance of the BD RST was evaluated in comparison


to a control serum gel tube at initial time. In addition, 24-hour Lithium
10x
stability was assessed for all analytes. Heparin
365965 Green

Improving a Source of Specimen Rejection


Hemolysis results from the degradation or lysis of red cells Lithium
in blood samples and continues to be a frequent occurrence 365985 Mint Green Heparin
and Gel 10x
in clinical laboratories; prevalence may be as high as 3.3% for plasma
of routine specimens, accounting for up to 40%-70% of separation
unsuitable specimens. This is more than five times higher than 365987 Mint Green
other causes for specimen rejection.3 In addition, the presence
of hemolysis may alter laboratory-generated analytical results,
NaFl/
possibly causing certain analytes to be increased due to leakage Na2EDTA
10x
of red cell constituents or interference with the test method.4 365992 Grey
These issues contribute to increased time to test results and
necessitate repeat collection by phlebotomy.
Clot
All tubes in the studies were evaluated for hemolysis (trace level Activator
365967 Gold
and Gel 5x
or higher). The results demonstrated a significant reduction in
for serum
hemolysis in the BD RST as compared to a control serum gel separation
tube when specimens were collected via routine venipuncture. 365978 Gold
The hemolysis rate in the BD RST was 28/1034 samples
(2.71%), while the serum gel tube exhibited a rate of 32/579
samples (5.53%). This reduction in hemolysis may improve No additive 0x
specimen quality and preclude the need for repeat draws. 365963 Red

Todays demands for improvements in laboratory workflow


and turnaround time remain a challenge for healthcare
Processing of Tubes
professionals. The reduced clot time of the BD RST can aid
in decreasing sample processing time, which may significantly Why
enhance patient throughput. This is particularly vital for units Most tubes contain an additive
or clot activator that needs to be
of the hospital in which test results drive important medical
mixed with the blood sample.
decisions on patient treatment.
Tubes with anticoagulants such
as EDTA need to be mixed to
For inquiries on the BD RST, please contact
ensure the specimen
BD Technical Services at 1-800-631-0174 or does not clot.
contact your local BD Sales Consultant.
How
* Brands are trademarks of their respective owners.
Holding tube upright, gently invert 180
and back.
REFERENCES Repeat movement as prescribed for each tube.
1. Hawkins RC. Laboratory turnaround time. Clin Biochem Rev 2007;28:179-194.
2. P rusa R, Doupovcova J, Warunek D, Stankovic A. Improving laboratory efficiencies
When
through significant time reduction in the preanalytical phase. Clin Chem Lab Med Immediately after drawing.
2009:Accepted for publication.
Consequences if not mixed
3. L ippi G, Blanckaert N, Bonini P, Green S, et al. Haemolysis: An overview of the
leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med
Tubes with anticoagulants will clot.
2008;46:764-772. BD SST tubes may not clot completely.
4. S onntag O. Haemolysis as an interference factor in clinical chemistry. Specimen will often need to be recollected.
J Clin Chem Clin Biochem 1986;24:127-139.

LabNotes: a newsletter from BD Diagnostics Preanalytical Systems, Volume 20, No.1, 2009
BD Global Technical Services
The BD Global Technical Services We have a knowledgeable and
department provides assistance professional team of Medical
Access Our Library of with a variety of topics regarding Technologists (ASCP certified)

Clinical White Papers blood and urine collection, phle-


botomy, literature, data support
on staff, ready to help with your
technical product questions.
and product related questions.
online!
Phone: 800.631.0174 (US only)
Fax: 201.847.5929
The BD Diagnostics Preanalytical Systems Library of Clini-
cal White Papers supports the use of the BD Vacutainer E-mail: www.bd.com/vacutainer/contact
and BD Microtainer family of products. We offer a com-
plete system of venous, capillary, and urine collection prod-
ucts that are optimally designed and tested for controlling
preanalytical variability throughout the specimen collection
and transport process.

This compilation of studies covers a vast array of analytes


to document the efficacy, performance characteristics, and BD Vacutainer
ease of use of our products. Unless otherwise noted, these Push Button Blood Collection Set
clinical white papers have been researched and written on Clinically demonstrated to
behalf of BD by BD associates. reduce needlestick injuries.

To ensure that your facility has the most


current version of BD Clinical White Papers:
Visit this website regularly to review our library NEW! Case Study in Joint
of BD Clinical White Papers Commission Journal on Quality
and Patient Safety
www.bd.com/vacutainer
Click on Library of Clinical Documentation/White Papers www.bd.com/JCAHO_study

BD Diagnostics Preanalytical Systems


1 Becton Drive, Franklin Lakes, NJ 07417 USA PRESORTED
FIRST-CLASS MAIL
BD Global Technical Services: 800.631.0174 U.S. POSTAGE
BD Customer Service: 888.237.2762 PAID

LabNotes
BD

A Newsletter from Volume 20, No.1, 2009


BD Diagnostics
Preanalytical Systems
IN THISISSUE
 apillary Blood Collection:
C
Best Practices
 uality Serum Specimens with the
Q
Speed of Plasma Introducing the
BD Vacutainer Rapid Serum Tube

Unless otherwise noted, BD, BD


Logo and all other trademarks are
property of Becton, Dickinson and
Company. 2009 BD Printed in USA
www.bd.com/vacutainer
11/09 VS8152

S-ar putea să vă placă și